Accountant supermarket manager <a href=" http://www.amritsartimes.com/diamox-sr-250-mg-capsules.pdf#preliminary ">content of tablet diamox</a> Perjeta, developed by Roche&#8217;s Genentech unit, was approved last year to treat women whose breast cancer tests positive for a protein called HER2, if the cancer has spread beyond the breast. Perjeta helps block the HER2 protein. HER2 positive cancer is believed to account for 20% to 25% of all breast-cancer cases.